Bright and early : inhibiting human cytomegalovirus by targeting major immediate-early gene expression or protein function
MetadataShow full item record
Altmetrics Handle Statistics
Altmetrics DOI Statistics
The human cytomegalovirus (HCMV), one of eight human herpesviruses, establishes lifelong latent infections in most people worldwide. Primary or reactivated HCMV infections cause severe disease in immunosuppressed patients and congenital defects in children. There is no vaccine for HCMV, and the currently approved antivirals come with major limitations. Most approved HCMV antivirals target late molecular processes in the viral replication cycle including DNA replication and packaging. “Bright and early” events in HCMV infection have not been exploited for systemic prevention or treatment of disease. Initiation of HCMV replication depends on transcription from the viral major immediate-early (IE) gene. Alternative transcripts produced from this gene give rise to the IE1 and IE2 families of viral proteins, which localize to the host cell nucleus.The IE1 and IE2 proteins are believed to control all subsequent early and late events in HCMV replication, including reactivation from latency, in part by antagonizing intrinsic and innate immune responses. Here we provide an update on the regulation of major IE gene expression and the functions of IE1 and IE2 proteins. We will relate this insight to experimental approaches that target IE gene expression or protein function via molecular gene silencing and editing or small chemical inhibitors.
Adamson , C S & Nevels , M M 2020 , ' Bright and early : inhibiting human cytomegalovirus by targeting major immediate-early gene expression or protein function ' , Viruses , vol. 12 , no. 1 , 110 . https://doi.org/10.3390/v12010110
Copyright © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
DescriptionFunding: UK Medical Research Council, grant number MR/P022146/1 (M.M.N.).
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.